Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,766 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06862102Recruiting
Multiple HPV Infections and Cervical Lesion Risk
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
Pavia, PaviaAges 18 years+ - NCT06868641Recruiting
Study for people stopping long-acting injectable PrEP
This study follows people who are stopping long-acting injectable PrEP (cabotegravir or lenacapavir). It checks how long the drug stays in your body and helps make sure you stay protected during that time. You'll do monthly video visits, mail in blood samples, and fill out short surveys.
New York, New YorkAges 18 years+ - NCT06869096Recruiting
Flushing liquid during colorectal cancer surgery
This trial compares two different liquids used to flush the surgical area during colorectal cancer surgery to see which one better prevents infections. If you are having surgery for colorectal cancer, you may be able to join.
Nanchong, SichuanAges 18–85 - NCT06870019Recruiting
Hepatitis C tracker study for unsheltered homelessness
This study tests a simple treatment for Hepatitis C in people experiencing unsheltered homelessness. It aims to help those who are receiving street medicine care and have not been treated before.
Alhambra, CaliforniaAges 18 years+ - NCT06870409RecruitingPhase 3
Phages plus antibiotics for heart infection treatment
This trial tests if adding bacteriophages (viruses that kill bacteria) to standard antibiotic treatment can help people with a serious heart valve infection called infective endocarditis. It may offer a new way to fight the infection.
MoscowAges 18 years+ - NCT06873308Recruiting
Infection activity in travelers and migrants with chronic schistosomiasis
This trial looks at how active a long-term schistosomiasis infection is in travelers and migrants. It aims to better understand the infection to help guide treatment.
AntwerpAges 5 years+ - NCT06874127Recruiting
Predicting liver repair in hepatitis B after treatment
This study looks at whether non-invasive tests can tell if liver damage is reversing in people with hepatitis B who have been on antiviral therapy for at least a year. It aims to help avoid repeated liver biopsies.
BeijingAges 18 years+ - NCT06876259Recruiting
AI tool to reduce antibiotics for young children with colds
This trial tests whether an artificial intelligence (AI) tool can help doctors decide when antibiotics are not needed for young children with colds. It aims to reduce unnecessary antibiotic use.
Pittsburgh, PennsylvaniaAges 6 months–2 years - NCT06877793Recruiting
Using dye imaging to diagnose severe flesh-eating infections
This trial tests a new way to quickly diagnose necrotizing soft tissue infections (NSTIs, also called flesh-eating infections) using a safe dye and a camera. If you are being checked for a possible NSTI, this could help doctors decide faster whether you have it and need treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT06886971Recruiting
Strategies to help youth with HIV stay virally suppressed
This trial tests a strategy to help young people with HIV keep their virus levels low. It focuses on using a long-acting injectable medication combination (Cabotegravir and Rilpivirine) and requires communication with your HIV doctor.
Baltimore, MarylandAges 12–30 - NCT06889805Recruiting
HDV screening for HIV and hepatitis B patients
This study tests whether people with both HIV and chronic hepatitis B should be checked for a third liver virus called HDV (hepatitis D). It helps find hidden infections so they can get the right care.
Hong KongAges 18 years+ - NCT06892015Recruiting
Oropouche virus shedding and immune response study
This study monitors how long the Oropouche virus stays in the body and how the immune system responds after a positive diagnosis. It may help us better understand the course of the infection and improve patient care.
Negrar, VRAges 18 years+ - NCT06894901Recruiting
Testing mosquito release to stop dengue clusters in public housing
This trial tests a new way to reduce dengue outbreaks by releasing special mosquitoes in public housing areas with active dengue clusters. If your neighborhood has a recent cluster of at least 10 cases, you may be part of the study.
SingaporeAges Any age - NCT06896370Recruiting
Gastric cancer study for people with high-risk H. pylori
This study follows people who carry a high-risk type of Helicobacter pylori (a stomach bacteria) to see if they develop gastric cancer. It aims to understand who is most at risk and how to monitor them over time.
TonglingAges 40 years+ - NCT06897943Recruiting
Gonococcal arthritis study (2014-2024)
This study looks at people who had a joint infection caused by gonorrhea bacteria between 2014 and 2024. Researchers want to learn more about how common this condition is and how it affects people.
Rennes, Brittany RegionAges Any age - NCT06899087Recruiting
Signals of infected pancreatic necrosis from blood
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
Minneapolis, MinnesotaAges 18 years+ - NCT06905119Recruiting
Smartphone app for managing PICC line care
This study tests a smartphone app to help manage care for people with a PICC (a long-term IV line). It aims to improve communication and monitoring during treatment at home.
Pamplona, NavarreAges 18 years+ - NCT06907056RecruitingPhase 4
A study on a simpler HIV medication combination
This study tests if a two-drug HIV regimen (darunavir/cobicistat plus lamivudine) works as well as a standard three-drug regimen in men whose HIV is already well-controlled. If effective, this could mean taking fewer medications.
Mexico City, Mexico CityAges 18–70 - NCT06907199RecruitingPhase 1
Antibiotic vs. bladder treatment plus antibiotic for recurrent UTIs
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
Kansas City, KansasAges 18–85 - NCT06907498Recruiting
Comparing two drugs for Dientamoeba fragilis stomach issues
This trial tests if paromomycin or metronidazole works better for adults with ongoing stomach problems caused by a parasite called Dientamoeba fragilis. These symptoms (pain, bloating, diarrhea) must have lasted more than a month, and no other cause has been found.
Ramat Gan, IsraelAges 18 years+ - NCT06907667Recruiting
Do timing of flu shot affect protection in kidney failure?
This study looks at whether getting a flu shot at a different time of day affects how well it works in people with chronic kidney failure, including those on dialysis or with a kidney transplant. Researchers want to see if timing can improve the body's immune response to the vaccine.
Nice, Alpes-MaritimesAges 18–100 - NCT06909188Recruiting
Helicobacter infection in bile duct cancer patients
This study looks for links between Helicobacter bacteria and cancers of the bile ducts and gallbladder. It compares patients with bile duct cancer, people having gallbladder surgery for non-cancer reasons, and healthy liver donors.
New Delhi, National Capital Territory of DelhiAges 18 years+ - NCT06911658Recruiting
Infection risk after esophagus cancer surgery
This study looks at infections that can happen after surgery to remove the esophagus (esophagectomy) for cancer. Understanding these infections may help doctors improve care after this procedure.
ParisAges 18 years+ - NCT06916195Recruiting
CMV virus reactivation in kids after stem cell transplant
This study looks at how often a common virus (CMV) becomes active again in children after a stem cell transplant from a donor. It will help doctors understand more about this risk and how to manage it.
GenovaAges birth–18 years
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,766 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.